Sfoglia per AUTORE
PARDO B
Collezione ASL Biella
Items : 1
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. in British journal of cancer / Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.
2023
AOU Città della Salute di Torino
ASL Biella
AOU Città della Salute di Torino
ASL Biella
Poveda A; Tsibulak I; Wimberger P; Heinzelmann-Schwarz V; Westermann A; Aglietta M; Arcangeli V; Zamagni C; Bologna A; Benedetti Panici P; Zola P; De Giorgi U; DeCensi A; Tognon G; Rubio-Pérez MJ; Pardo B; Romeo M; Tasca G; Funari G; Iglesias M; Biagioli E; Barretina-Ginesta MP; Deryal M; Mirza MR; Fossati R; Herbertson R; Riniker S; Nyvang GB; Chekerov R; et alii...